top of page
800-958-1129 (TTY: 711)
We are open M-F 8:00 a.m. – 8:00 p.m. PT. Between 10/1 and 3/31, we are open 7 days a week, except for the major year-end holidays.
_edited.png){kind=logo}
National Medicare Coverage Determinations
ID | Title | Link Title |
|---|---|---|
190.17 | Prothrombin Time (PT) | NCD - Prothrombin Time (PT) (190.17) (cms.gov) |
190.18 | Serum Iron Studies | NCD - Serum Iron Studies (190.18) (cms.gov) |
190.19 | Collagen Crosslinks, any Method | NCD - Collagen Crosslinks, any Method (190.19) (cms.gov) |
190.2 | Diagnostic Pap Smears | NCD - Diagnostic Pap Smears (190.2) (cms.gov) |
190.20 | Blood Glucose Testing | NCD - Blood Glucose Testing (190.20) (cms.gov) |
190.21 | Glycated Hemoglobin/Glycated Protein | NCD - Glycated Hemoglobin/Glycated Protein (190.21) (cms.gov) |
190.22 | Thyroid Testing | NCD - Thyroid Testing (190.22) (cms.gov) |
190.23 | Lipid Testing | NCD - Lipid Testing (190.23) (cms.gov) |
190.24 | Digoxin Therapeutic Drug Assay | NCD - Digoxin Therapeutic Drug Assay (190.24) (cms.gov) |
190.25 | Alpha-fetoprotein | NCD - Alpha-fetoprotein (190.25) (cms.gov) |
190.26 | Carcinoembryonic Antigen | NCD - Carcinoembryonic Antigen (190.26) (cms.gov) |
190.27 | Human Chorionic Gonadotropin | NCD - Human Chorionic Gonadotropin (190.27) (cms.gov) |
190.28 | Tumor Antigen by Immunoassay - CA 125 | NCD - Tumor Antigen by Immunoassay - CA 125 (190.28) (cms.gov) |
190.29 | Tumor Antigen by Immunoassay - CA 15-3/CA 27.29 | NCD - Tumor Antigen by Immunoassay - CA 15-3/CA 27.29 (190.29) (cms.gov) |
190.3 | Cytogenetic Studies | NCD - Cytogenetic Studies (190.3) (cms.gov) |
190.30 | Tumor Antigen by Immunoassay - CA 19-9 | NCD - Tumor Antigen by Immunoassay - CA 19-9 (190.30) (cms.gov) |
190.31 | Prostate Specific Antigen | NCD - Prostate Specific Antigen (190.31) (cms.gov) |
190.32 | Gamma Glutamyl Transferase | NCD - Gamma Glutamyl Transferase (190.32) (cms.gov) |
190.33 | Hepatitis Panel/Acute Hepatitis Panel | NCD - Hepatitis Panel/Acute Hepatitis Panel (190.33) (cms.gov) |
190.34 | Fecal Occult Blood Test | NCD - Fecal Occult Blood Test (190.34) (cms.gov) |
190.5 | Sweat Test | NCD - Sweat Test (190.5) (cms.gov) |
190.6 | Hair Analysis | NCD - Hair Analysis (190.6) (cms.gov) |
190.7 | Human Tumor Stem Cell Drug Sensitivity Assays | NCD - Human Tumor Stem Cell Drug Sensitivity Assays (190.7) (cms.gov) |
190.8 | Lymphocyte Mitogen Response Assays | NCD - Lymphocyte Mitogen Response Assays (190.8) (cms.gov) |
190.9 | Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS) | NCD - Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS) (190.9) (cms.gov) |
20.1 | Vertebral Artery Surgery | NCD - Vertebral Artery Surgery (20.1) (cms.gov) |
20.10.1 | Cardiac Rehabilitation Programs for Chronic Heart Failure | NCD - Cardiac Rehabilitation Programs for Chronic Heart Failure (20.10.1) (cms.gov) |
20.11 | Intraoperative Ventricular Mapping | NCD - Intraoperative Ventricular Mapping (20.11) (cms.gov) |
20.12 | Diagnostic Endocardial Electrical Stimulation (Pacing) | NCD - Diagnostic Endocardial Electrical Stimulation (Pacing) (20.12) (cms.gov) |
20.13 | HIS Bundle Study | NCD - HIS Bundle Study (20.13) (cms.gov) |
20.14 | Plethysmography | NCD - Plethysmography (20.14) (cms.gov) |
20.15 | Electrocardiographic Services | NCD - Electrocardiographic Services (20.15) (cms.gov) |
20.16 | Cardiac Output Monitoring by Thoracic Electrical Bioimpedance (TEB) | NCD - Cardiac Output Monitoring by Thoracic Electrical Bioimpedance (TEB) (20.16) (cms.gov) |
20.17 | Noninvasive Tests of Carotid Function | NCD - Noninvasive Tests of Carotid Function (20.17) (cms.gov) |
20.18 | Carotid Body Resection/Carotid Body Denervation | NCD - Carotid Body Resection/Carotid Body Denervation (20.18) (cms.gov) |
20.19 | Ambulatory Blood Pressure Monitoring | NCD - Ambulatory Blood Pressure Monitoring (20.19) (cms.gov) |
20.2 | Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery | NCD - Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery (20.2) (cms.gov) |
20.20 | External Counterpulsation (ECP) Therapy for Severe Angina | NCD - External Counterpulsation (ECP) Therapy for Severe Angina (20.20) (cms.gov) |
20.21 | Chelation Therapy for Treatment of Atherosclerosis | NCD - Chelation Therapy for Treatment of Atherosclerosis (20.21) (cms.gov) |
20.22 | Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis | NCD - Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis (20.22) (cms.gov) |
20.23 | Fabric Wrapping of Abdominal Aneurysms | NCD - Fabric Wrapping of Abdominal Aneurysms (20.23) (cms.gov) |
20.24 | Displacement Cardiography | NCD - Displacement Cardiography (20.24) (cms.gov) |
20.25 | Cardiac Catheterization Performed in Other than a Hospital Setting - RETIRED | NCD - Cardiac Catheterization Performed in Other than a Hospital Setting - RETIRED (20.25) (cms.gov) |
20.26 | Partial Ventriculectomy | NCD - Partial Ventriculectomy (20.26) (cms.gov) |
20.27 | Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test | NCD - Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test (20.27) (cms.gov) |
20.28 | Therapeutic Embolization | NCD - Therapeutic Embolization (20.28) (cms.gov) |
20.29 | Hyperbaric Oxygen Therapy | NCD - Hyperbaric Oxygen Therapy (20.29) (cms.gov) |
20.3 | Thoracic Duct Drainage (TDD) in Renal Transplants | NCD - Thoracic Duct Drainage (TDD) in Renal Transplants (20.3) (cms.gov) |
20.30 | Microvolt T-Wave Alternans (MTWA) | NCD - Microvolt T-Wave Alternans (MTWA) (20.30) (cms.gov) |
20.31 | Intensive Cardiac Rehabilitation (ICR) Programs | NCD - Intensive Cardiac Rehabilitation (ICR) Programs (20.31) (cms.gov) |
20.31.1 | The Pritikin Program | NCD - The Pritikin Program (20.31.1) (cms.gov) |
20.31.2 | Ornish Program for Reversing Heart Disease | NCD - Ornish Program for Reversing Heart Disease (20.31.2) (cms.gov) |
20.31.3 | Benson-Henry Institute Cardiac Wellness Program | NCD - Benson-Henry Institute Cardiac Wellness Program (20.31.3) (cms.gov) |
20.32 | Transcatheter Aortic Valve Replacement (TAVR) | NCD - Transcatheter Aortic Valve Replacement (TAVR) (20.32) (cms.gov) |
20.33 | Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve Regurgitation | NCD - Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve Regurgitation (20.33) (cms.gov) |
20.34 | Percutaneous Left Atrial Appendage Closure (LAAC) | NCD - Percutaneous Left Atrial Appendage Closure (LAAC) (20.34) (cms.gov) |
20.35 | Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD) | NCD - Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD) (20.35) (cms.gov) |
20.4 | Implantable Cardioverter Defibrillators (ICDs) | NCD - Implantable Cardioverter Defibrillators (ICDs) (20.4) (cms.gov) |
20.6 | Transmyocardial Revascularization (TMR) | NCD - Transmyocardial Revascularization (TMR) (20.6) (cms.gov) |
20.7 | Percutaneous Transluminal Angioplasty (PTA) | NCD - Percutaneous Transluminal Angioplasty (PTA) (20.7) (cms.gov) |
20.8 | Cardiac Pacemakers | NCD - Cardiac Pacemakers (20.8) (cms.gov) |
20.8.1 | Cardiac Pacemaker Evaluation Services | NCD - Cardiac Pacemaker Evaluation Services (20.8.1) (cms.gov) |
20.8.1.1 | Transtelephonic Monitoring of Cardiac Pacemakers | NCD - Transtelephonic Monitoring of Cardiac Pacemakers (20.8.1.1) (cms.gov) |
20.8.2 | Self-Contained Pacemaker Monitors | NCD - Self-Contained Pacemaker Monitors (20.8.2) (cms.gov) |
20.8.3 | Cardiac Pacemakers: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers | NCD - Cardiac Pacemakers: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers (20.8.3) (cms.gov) |
20.8.4 | Leadless Pacemakers | NCD - Leadless Pacemakers (20.8.4) (cms.gov) |
20.9.1 | Ventricular Assist Devices | NCD - Ventricular Assist Devices (20.9.1) (cms.gov) |
200.1 | Nesiritide for Treatment of Heart Failure Patients | NCD - Nesiritide for Treatment of Heart Failure Patients (200.1) (cms.gov) |
200.2 | Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases | NCD - Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases (200.2) (cms.gov) |
200.3 | Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD) | NCD - Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD) (200.3) (cms.gov) |
210.1 | Prostate Cancer Screening Tests | NCD - Prostate Cancer Screening Tests (210.1) (cms.gov) |
210.10 | Screening for Sexually Transmitted Infections (STIs) and High-Intensity Behavioral Counseling (HIBC) to Prevent STIs | NCD - Screening for Sexually Transmitted Infections (STIs) and High-Intensity Behavioral Counseling (HIBC) to Prevent STIs (210.10) (cms.gov) |
210.11 | Intensive Behavioral Therapy for Cardiovascular Disease | NCD - Intensive Behavioral Therapy for Cardiovascular Disease (210.11) (cms.gov) |
210.12 | Intensive Behavioral Therapy for Obesity | NCD - Intensive Behavioral Therapy for Obesity (210.12) (cms.gov) |
210.13 | Screening for Hepatitis C Virus (HCV) in Adults | NCD - Screening for Hepatitis C Virus (HCV) in Adults (210.13) (cms.gov) |
210.14 | Lung Cancer Screening with Low Dose Computed Tomography (LDCT) | NCD - Lung Cancer Screening with Low Dose Computed Tomography (LDCT) (210.14) (cms.gov) |
210.2 | Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer | NCD - Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer (210.2) (cms.gov) |
210.2.1 | Screening for Cervical Cancer with Human Papillomavirus (HPV) | NCD - Screening for Cervical Cancer with Human Papillomavirus (HPV) (210.2.1) (cms.gov) |
210.3 | Colorectal Cancer Screening Tests | NCD - Colorectal Cancer Screening Tests (210.3) (cms.gov) |
210.4.1 | Counseling to Prevent Tobacco Use | NCD - Counseling to Prevent Tobacco Use (210.4.1) (cms.gov) |
210.6 | Screening for Hepatitis B Virus (HBV) Infection | NCD - Screening for Hepatitis B Virus (HBV) Infection (210.6) (cms.gov) |
210.7 | Screening for the Human Immunodeficiency Virus (HIV) Infection | NCD - Screening for the Human Immunodeficiency Virus (HIV) Infection (210.7) (cms.gov) |
210.8 | Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse | NCD - Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse (210.8) (cms.gov) |
210.9 | Screening for Depression in Adults | NCD - Screening for Depression in Adults (210.9) (cms.gov) |
220.1 | Computed Tomography | NCD - Computed Tomography (220.1) (cms.gov) |
220.10 | Portable Hand-Held X-Ray Instrument | NCD - Portable Hand-Held X-Ray Instrument (220.10) (cms.gov) |
220.11 | Thermography | NCD - Thermography (220.11) (cms.gov) |
220.12 | Single Photon Emission Computed Tomography (SPECT) | NCD - Single Photon Emission Computed Tomography (SPECT) (220.12) (cms.gov) |
220.13 | Percutaneous Image-Guided Breast Biopsy | NCD - Percutaneous Image-Guided Breast Biopsy (220.13) (cms.gov) |
220.2 | Magnetic Resonance Imaging | NCD - Magnetic Resonance Imaging (220.2) (cms.gov) |
220.4 | Mammograms | NCD - Mammograms (220.4) (cms.gov) |
220.5 | Ultrasound Diagnostic Procedures | NCD - Ultrasound Diagnostic Procedures (220.5) (cms.gov) |
220.6.1 | PET for Perfusion of the Heart | NCD - PET for Perfusion of the Heart (220.6.1) (cms.gov) |
220.6.13 | FDG PET for Dementia and Neurodegenerative Diseases | NCD - FDG PET for Dementia and Neurodegenerative Diseases (220.6.13) (cms.gov) |
220.6.17 | Positron Emission Tomography (FDG) for Oncologic Conditions | NCD - Positron Emission Tomography (FDG) for Oncologic Conditions (220.6.17) (cms.gov) |
220.6.19 | Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer | NCD - Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (220.6.19) (cms.gov) |
220.6.20 | Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease | NCD - Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease (220.6.20) (cms.gov) |
220.6.8 | FDG PET for Myocardial Viability | NCD - FDG PET for Myocardial Viability (220.6.8) (cms.gov) |
220.6.9 | FDG PET for Refractory Seizures | NCD - FDG PET for Refractory Seizures (220.6.9) (cms.gov) |
220.9 | Digital Subtraction Angiography | NCD - Digital Subtraction Angiography (220.9) (cms.gov) |
X
​You are about to leave Elite Health Plan website
and go to another site managed by a third party. Once you leave our website, the policies and practices of that site may differ from those of Elite Health Plan. When visiting a third-party website, you will be subject to the privacy and security policies of that specific website.
bottom of page